New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

New research suggests that a novel drug molecule could lead to treatments preventing Parkinson’s disease in younger patients.

Researchers at Karolinska Institutet have identified a mechanism responsible for a serious psychiatric complication caused by ...

The NHS has committed to ending deadly delays in giving “time critical” medication to Parkinson’s patients in hospital, The ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health ...